EMPEROR-Preserved: SGLT2 inhibitors breakthrough in the management of heart failure with preserved ejection fraction.

Wagdy, Kerolos; Nagy, Sherif

Wagdy, Kerolos; Nagy, Sherif.

Afiliação

Wagdy K; Aswan Heart Centre, Division of Cardiology, Aswan, Egypt.
Nagy S; Aswan Heart Centre, Division of Cardiology, Aswan, Egypt.

Glob Cardiol Sci Pract ; 2021(3): e202117, 2021 Oct 30.

Article em En | MEDLINE | ID: mdl-34805375

Texto completo

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8587377
https://dx.doi.org/10.21542/gcsp.2021.17

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Risk_factors_studies Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8587377
https://dx.doi.org/10.21542/gcsp.2021.17

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Risk_factors_studies Idioma: En Ano de publicação: 2021 Tipo de documento: Article